SOURCE: Datascope Corp.

November 02, 2005 16:23 ET

Datascope Confirms Agreement to Acquire Endoscopic Vessel Harvesting Business from Ethicon, Inc.

MONTVALE, NJ -- (MARKET WIRE) -- November 2, 2005 -- Datascope Corp. (NASDAQ: DSCP) confirmed that, as announced by the Federal Trade Commission today, Datascope has entered into a definitive agreement with Ethicon, Inc., a Johnson & Johnson company, to acquire the Clearglide® endoscopic vessel harvesting product line of Ethicon's CardioVations division. This transaction is contingent on the closing of the acquisition by Johnson & Johnson of Guidant Corporation as well as the satisfaction of other typical conditions. Johnson & Johnson today stated that it believes that it is not required under the terms of its agreement with Guidant to close that transaction. Johnson & Johnson also announced today that there can be no assurance that it will reach agreement with Guidant on revised terms of their transaction. Datascope is entitled to a termination fee in the event its acquisition of the endoscopic vessel harvesting business does not close due to the failure of the Johnson & Johnson transaction with Guidant to close.

ABOUT DATASCOPE CORP.

Datascope Corp. is a diversified medical device company that manufactures and markets proprietary products for clinical health care markets in interventional cardiology and radiology, cardiovascular and vascular surgery, anesthesiology, emergency medicine and critical care. Datascope's news releases and other company information can be found on the company's website, http://www.datascope.com.

Contact Information

  • For Information Contact:
    Rachel Winokur
    Corporate Director, Business Development
    Datascope Corp.
    14 Phillips Parkway
    Montvale, NJ 07645
    (201) 307-5429
    www.datascope.com